Background/Objective: The aim of this study was to examine the blood gene expression and methylation of ATP-binding cassette sub-family A member 7 gene (ABCA7) as a biological marker of AD.
Methods: AD subjects (n = 50; 11 males, 77.7±6.05 years old) and age- and sex-matched healthy controls (n = 50) were recruited. A single nucleotide polymorphism in ABCA7 (rs3764650), methylation rates of CpG sites in the ABCA7 promoter region, and ABCA7 mRNA expression levels in peripheral blood were examined.
Results: The distribution of the rs3764650 polymorphism in AD subjects was not different from that of controls. Although the methylation rates of AD subjects were not significantly different from those of controls, the ABCA7 mRNA expression level in AD subjects was significantly higher than that in controls. Additionally, the ABCA7 mRNA expression level in AD subjects was significantly correlated with Mini-Mental State Examination recall, the Alzheimer’s Disease Assessment Scale total score, and the Clinical Dementia Rating score. We also found a significant correlation between the ABCA7 mRNA expression level and duration of illness.
Conclusion: The ABCA7 mRNA expression level in peripheral blood may be a marker for early stages of AD and disease progression regardless of rs3764650 and the methylation rate of its promoter.
JormAF (1986) Effects of cholinergic enhancement therapies on memory function in Alzheimer’s disease: A meta-analysis of the literature. Aust N Z J Psychiatry20, 237–240.
2.
WilkinsonDG, FrancisPT, SchwamE, Payne-ParrishJ (2004) Cholinesterase inhibitors used in the treatment of Alzheimer’s disease: The relationship between pharmacological effects and clinical efficacy. Drugs Aging21, 453–478.
3.
SlooterAJ, CrutsM, KalmijnS, HofmanA, BretelerMM, Van BroeckhovenC, van DuijnCM (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam Study. Arch Neurol55, 964–968.
KimWS, GuilleminGJ, GlarosEN, LimCK, GarnerB (2006) Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells. Neuroreport17, 891–896.
11.
KimWS, WeickertCS, GarnerB (2008) Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J Neurochem104, 1145–1166.
12.
KimWS, LiH, RuberuK, ChanS, ElliottDA, LowJK, ChengD, KarlT, GarnerB (2013) Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer’s disease. J Neurosci33, 4387–4394.
13.
WangN, LanD, Gerbod-GiannoneM, Linsel-NitschkeP, JehleAW, ChenW, MartinezLO, TallAR (2003) ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J Biol Chem278, 42906–42912.
FuY, HsiaoJH, PaxinosG, HallidayGM, KimWS (2016) ABCA7 mediates phagocytic clearance of amyloid-β in the brain. J Alzheimers Dis54, 569–584.
16.
LiaoYC, LeeWJ, HwangJP, WangYF, TsaiCF, WangPN, WangSJ, FuhJL (2014) ABCA7 gene and the risk of Alzheimer’s disease in Han Chinese in Taiwan. Neurobiol Aging35, 2423.e7–2423.e13.
17.
LiuG, LiF, ZhangS, JiangY, MaG, ShangH, LiuJ, FengR, ZhangL, LiaoM, ZhaoB, LiK (2014) Analyzing large-scale samples confirms the association between the ABCA7 rs3764650 polymorphism and Alzheimer’s disease susceptibility. Mol Neurobiol50, 757–764.
18.
VasquezJB, FardoDW, EstusS (2013) ABCA7 expression is associated with Alzheimer’s disease polymorphism and disease status. Neurosci Lett556, 58–62.
19.
YuL, ChibnikLB, SrivastavaGP, PochetN, YangJ, XuJ, KozubekJ, ObholzerN, LeurgansSE, SchneiderJA, MeissnerA, De JagerPL, BennettDA (2015) Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol72, 15–24.
MoriY, YoshinoY, OchiS, YamazakiK, KawabeK, AbeM, KitanoT, OzakiY, YoshidaT, NumataS, MoriT, IgaJ, KurodaN, OhmoriT, UenoS (2015) TREM2 mRNA expression in leukocytes is increased in Alzheimer’s disease and schizophrenia. PLoS One10, e0136835.
22.
YamazakiK, YoshinoY, MoriT, OkitaM, YoshidaT, MoriY, OzakiY, SaoT, IgaJ, UenoS (2016) Association study and meta-analysis of polymorphisms, methylation profiles, and peripheral mRNA expression of the serotonin transporter gene in patients with Alzheimer’s disease. Dement Geriatr Cogn Disord41, 334–347.
23.
YoshinoY, MoriT, YoshidaT, YamazakiK, OzakiY, SaoT, FunahashiY, IgaJI, UenoSI (2016) Elevated mRNA expression and low methylation of SNCA in Japanese Alzheimer’s disease subjects. J Alzheimers Dis54, 1349–1357.
24.
FunahashiY, YoshinoY, YamazakiK, MoriY, MoriT, OzakiY, SaoT, OchiS, IgaJI, UenoSI (2017) DNA methylation changes at SNCA intron 1 in patients with dementia with Lewy bodies. Psychiatry Clin Neurosci71, 28–35.
25.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCRJr, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
26.
FolsteinMF, FolsteinSE, McHughPR (1975) “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res12, 189–198.
27.
MorrisJC (1993) The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology43, 2412–2414.
28.
CummingsJL, MegaM, GrayK, Rosenberg-ThompsonS, CarusiDA, GornbeinJ (1994) The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology44, 2308–2314.
29.
MathelierA, FornesO, ArenillasDJ, ChenCY, DenayG, LeeJ, ShiW, ShyrC, TanG, Worsley-HuntR, ZhangAW, ParcyF, LenhardB, SandelinA, WassermanWW (2016) JASPAR 2016: A major expansion and update of the open-access database of transcription factor binding profiles. Nucleic Acids Res44, D110–D115.
30.
SandelinA, AlkemaW, EngströmP, WassermanWW, LenhardB (2004) JASPAR: An open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res32, D91–D94.
31.
CarrolED, SalwayF, PepperSD, SaundersE, MankhamboLA, OllierWE, HartCA, DayP (2007) Successful downstream application of the Paxgene Blood RNA system from small blood samples in paediatric patients for quantitative PCR analysis. BMC Immunol8, 20.
32.
HuN, TanMS, YuJT, SunL, TanL, WangYL, JiangT, TanL (2014) Increased expression of TREM2 in peripheral blood of Alzheimer’s disease patients. J Alzheimers Dis38, 497–501.
33.
WatanabeS, IgaJ, NishiA, NumataS, KinoshitaM, KikuchiK, NakatakiM, OhmoriT (2014) Microarray analysis of global gene expression in leukocytes following lithium treatment. Hum Psychopharmacol Clin Exp29, 190–198.
34.
WatanabeSY, IgaJ, IshiiK, NumataS, ShimoderaS, FujitaH, OhmoriT (2015) Biological tests for major depressive disorder that involve leukocyte gene expression assays. J Psychiatr Res66-67, 1–6.
35.
LivakKJ, SchmittgenTD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods25, 402–408.
36.
KandaY (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant48, 452–458.
37.
RamirezLM, GoukasianN, PoratS, HwangKS, EastmanJA, HurtzS, WangB, VangN, SearsR, KleinE, CoppolaG, ApostolovaLG (2016) Common variants in ABCA7 and MS4A6A are associated with cortical and hippocampal atrophy. Neurobiol Aging39, 82–89.
38.
KimWS, FitzgeraldML, KangK, OkuhiraK, BellSA, ManningJJ, KoehnSL, LuN, MooreKJ, FreemanMW (2005) Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J Biol Chem280, 3989–3995.
39.
IkedaY, Abe-DohmaeS, MunehiraY, AokiR, KawamotoS, FuruyaA, ShitaraK, AmachiT, KiokaN, MatsuoM, YokoyamaS, UedaK (2003) Posttranscriptional regulation of human ABCA7 and its function for the apoA-I-dependent lipid release. Biochem Biophys Res Commun311, 313–318.
40.
LangmannT, MauererR, ZahnA, MoehleC, ProbstM, StremmelW, SchmitzG (2003) Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues. Clin Chem49, 230–238.
41.
ItagakiS, McGeerPL, AkiyamaH (1988) Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer’s disease brain tissue. Neurosci Lett91, 259–264.
42.
FisherY, NemirovskyA, BaronR, MonsonegoA (2010) T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer’s disease. PLoS One5, e10830.
43.
KarchCM, JengAT, NowotnyP, CadyJ, CruchagaC, GoateAM (2012) Expression of novel Alzheimer’s disease risk genes in control and Alzheimer’s disease brains. PLoS One7, e50976.
